Back
Cerence, Inc. 10K Form
Sell
23
CRNC
Cerence, Inc.
Last Price:
$7.93
Seasonality Move:
-15.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-08 | 10Q | CRNC/Cerence, Inc. Quarterly |
| 2020-11-19 | 10K | CRNC/Cerence, Inc. Annual |
| 2020-08-05 | 10Q | CRNC/Cerence, Inc. Quarterly |
| 2020-05-08 | 10Q | CRNC/Cerence, Inc. Quarterly |
| 2020-02-13 | 10Q | CRNC/Cerence, Inc. Quarterly |
| 2019-12-19 | 10K | CRNC/Cerence, Inc. Annual |
Receive CRNC News And Ratings
See the #1 stock for the next 7 days that we like better than CRNC
CRNC Financial Statistics
Sales & Book Value
| Annual Sales: | $251.8M |
|---|---|
| Cash Flow: | $35.6M |
| Price / Cash Flow: | 4.86 |
| Annual Sales: | $3.34 |
| Price / Book: | 2.37 |
Profitability
| EPS (TTM): | -0.02680 |
|---|---|
| Net Income (TTM): | $335K |
| Gross Margin: | $181.5M |
| Return on Equity: | 0.23% |
| Return on Assets: | 0.05% |
Cerence, Inc. Earnings Forecast
Key Cerence, Inc. Financial Ratios
-
The Gross Profit Margin over the past 10 years for CRNC is 72.07%.
-
The Selling, General & Administrative Expenses for CRNC have been equal to 28.03% of Gross Profit Margin.
-
The Research & Development expenses have been 38.83% of Revenue.
-
The Net Earning history of CRNC is -7.43% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Cerence, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | CRNC |
| CUSIP: | 156727 |
| Website: | cerence.com |
Debt
| Debt-to-Equity Ratio: | 1.25 |
|---|---|
| Current Ratio: | 1.83 |
| Quick Ratio: | 1.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 11.69 |
CRNC Technical Analysis vs Fundamental Analysis
Sell
23
Cerence, Inc. (CRNC)
is a Sell
Is Cerence, Inc. a Buy or a Sell?
-
Cerence, Inc. stock is rated a SellThe current Cerence, Inc. [CRNC] share price is $7.91. The Score for CRNC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.